Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nanobiotix S.A. ADR (NQ: NBTX ) 4.160 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Nanobiotix S.A. ADR < Previous 1 2 3 4 5 6 7 8 9 Next > NANOBIOTIX to Participate in Two Upcoming Investor Conferences May 11, 2022 From Nanobiotix Via Business Wire 7 Biotech Stocks With Key Catalysts for May May 11, 2022 The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. Via InvestorPlace Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital May 10, 2022 From Nanobiotix Via Business Wire NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022 May 04, 2022 From NANOBIOTIX Via Business Wire New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting May 02, 2022 From NANOBIOTIX Via Business Wire Nanobiotix's Radiotherapy Combo Therapy Shows Boosted Anti-Tumor Activity In Preclinical Studies April 12, 2022 Nanobiotix SA (NASDAQ: NBTX) Via Benzinga NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3 April 11, 2022 From NANOBOTIX Via Business Wire NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F April 08, 2022 From NANOBIOTIX Via Business Wire Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital April 07, 2022 From Nanobiotix Via Business Wire NANOBIOTIX Provides Business Update and Reports Full Year 2021 Financial Results March 30, 2022 From NANOBIOTIX Via Business Wire NANOBIOTIX to Announce Full Year 2021 Financial Results on March 30, 2022 March 16, 2022 From NANOBIOTIX Via Business Wire Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital February 10, 2022 From NANOBIOTIX Via Business Wire Earnings Scheduled For March 30, 2022 March 30, 2022 Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. Via Benzinga Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer February 09, 2022 From Nanobiotix Via Business Wire 12 Health Care Stocks Moving In Wednesday's Intraday Session February 02, 2022 Gainers Epizyme (NASDAQ:EPZM) stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6... Via Benzinga NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4 January 26, 2022 From NANOBIOTIX Via Business Wire Is Oncolytics Biotech's GOBLET Study Making Headway in the Fight Against Pancreatic and Colorectal Tumors? January 25, 2022 Photo by Lucas Vasques on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.... Via Benzinga Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital January 11, 2022 From Nanobiotix Via Business Wire NANOBIOTIX Provides Corporate Update and Highlights Key 2022 Milestone Targets January 10, 2022 From NANOBIOTIX Via Business Wire 58 Biggest Movers From Yesterday January 07, 2022 Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 06, 2022 Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's... Via Benzinga NANOBIOTIX Announces First Patient Enrolled in NANORAY-312 Global Phase III Registrational Study of NBTXR3 in Head and Neck Cancer January 05, 2022 From NANOBIOTIX Via Business Wire Nanobiotix Announces Participation at Three Virtual Investor Conferences in January 2022 January 04, 2022 From Nanobiotix Via Business Wire Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital December 08, 2021 From Nanobiotix Via Business Wire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 08, 2021 Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7... Via Benzinga NANOBIOTIX to Present at the 4th Annual Evercore ISI HealthCONx Conference November 17, 2021 From NANOBIOTIX Via Business Wire NANOBIOTIX Announces New Preclinical Data Highlighting NBTXR3 Immune Priming and Checkpoint Inhibitor Combination November 09, 2021 From NANOBIOTIX Via Business Wire Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital November 08, 2021 From Nanobiotix Via Business Wire The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance November 10, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... Via Benzinga Exposures COVID-19 NANOBIOTIX to Participate in a Fireside Chat at the Jefferies London Healthcare Conference November 03, 2021 From Nanobiotix Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
